TEAM - KATHY DUNSMORE

Kathy Dunsmore joined Hyku Biosciences in September of 2022. She is a skilled tumor cell biologist, with expertise in interrogating the biology and mechanism of clinical candidate molecules for novel targets. Prior to joining the company, she was a Senior Scientist of Cell Biology at a stealth mode local biotech company. She held roles of increasing scientific responsibility at Merck Research Laboratories, Cincinnati Children’s Research Foundation, and Cadus Pharmaceutics Corporation. She received her MS in Biochemistry from Texas A&M University.